The pathogenesis and treatment of hepatic encephalopathy: evidence for the involvement of benzodiazepine receptor ligands.
Basile
A S
AS
Laboratory of Neuroscience, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.
Jones
E A
EA
Skolnick
P
P
D000641:Ammonia / Q000378:metabolism; D000818:Animals; D004195:Disease Models, Animal; D005442:Flumazenil / Q000627:therapeutic use; D006501:Hepatic Encephalopathy / Q000209:etiology* / Q000628:therapy; D006801:Humans; D008024:Ligands; D018377:Neurotransmitter Agents / Q000502:physiology; D011963:Receptors, GABA-A / Q000187:drug effects / Q000502:physiology*
D008024:Ligands; D018377:Neurotransmitter Agents; D011963:Receptors, GABA-A; D005442:Flumazenil; D000641:Ammonia